Risk factors for hospitalizations and readmissions among individuals with sickle cell disease: results of a U.S. survey study.


Journal

Hematology (Amsterdam, Netherlands)
ISSN: 1607-8454
Titre abrégé: Hematology
Pays: England
ID NLM: 9708388

Informations de publication

Date de publication:
Dec 2019
Historique:
entrez: 28 11 2018
pubmed: 28 11 2018
medline: 12 12 2018
Statut: ppublish

Résumé

Hospital admissions are significant events in the care of individuals with sickle cell disease (SCD) due to associated costs and potential for quality of life compromise. This cross-sectional cohort study evaluated risk factors for admissions and readmissions between October 2014 and March 2016 in adults with SCD (n = 201) and caregivers of children with SCD (n = 330) at six centres across the U.S. Survey items assessed social determinants of health (e.g. educational attainment, difficulty paying bills), depressive symptoms, social support, health literacy, spirituality, missed clinic appointments, and outcomes hospital admissions and 30-day readmissions in the previous year. A majority of adults (64%) and almost half of children (reported by caregivers: 43%) were admitted, and fewer readmitted (adults: 28%; children: 9%). The most common reason for hospitalization was uncontrolled pain (admission: adults: 84%, children: 69%; readmissions: adults: 83%, children: 69%). Children were less likely to have admissions/readmissions than adults (Admissions: OR: 0.35, 95% CI: [0.23,0.52]); Readmissions: 0.23 [0.13,0.41]). For all participants, missing appointments were associated with admissions (1.66 [1.07, 2.58]) and readmissions (2.68 [1.28, 6.29]), as were depressive symptoms (admissions: 1.36 [1.16,1.59]; readmissions: 1.24 [1.04, 1.49]). In adults, difficulty paying bills was associated with more admissions, (3.11 [1.47,6.62]) readmissions (3.7 [1.76,7.79]), and higher spirituality was associated with fewer readmissions (0.39 [0.18,0.81]). Missing appointments was significantly associated with admissions and readmissions. Findings confirm that age, mental health, financial insecurity, spirituality, and clinic attendance are all modifiable factors that are associated with admissions and readmissions; addressing them could reduce hospitalizations.

Identifiants

pubmed: 30479187
doi: 10.1080/16078454.2018.1549801
pmc: PMC6349225
mid: NIHMS1515453
doi:

Types de publication

Clinical Trial Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-198

Subventions

Organisme : NHLBI NIH HHS
ID : K23 HL141447
Pays : United States

Références

Am Psychol. 2003 Jan;58(1):24-35
pubmed: 12674816
JAMA. 2003 Jun 18;289(23):3106-16
pubmed: 12813116
Med Care. 2003 Nov;41(11):1284-92
pubmed: 14583691
Health Qual Life Outcomes. 2004 May 13;2:24
pubmed: 15142277
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003350
pubmed: 16625580
J Gen Intern Med. 2006 Aug;21(8):874-7
pubmed: 16881950
J Gen Intern Med. 2008 May;23(5):561-6
pubmed: 18335281
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Pediatr Blood Cancer. 2009 Apr;52(4):481-5
pubmed: 19058209
Am J Hematol. 2009 Jun;84(6):323-7
pubmed: 19358302
Pediatr Blood Cancer. 2009 Oct;53(4):642-6
pubmed: 19492318
Am J Hematol. 2010 Jan;85(1):77-8
pubmed: 20029951
Blood. 2010 Apr 29;115(17):3447-52
pubmed: 20194891
Am J Prev Med. 2010 Apr;38(4 Suppl):S536-41
pubmed: 20331955
JAMA. 2010 Apr 7;303(13):1288-94
pubmed: 20371788
J Behav Med. 2011 Apr;34(2):120-7
pubmed: 20812027
Pediatr Blood Cancer. 2012 Mar;58(3):406-9
pubmed: 21495162
Pediatr Blood Cancer. 2012 Jan;58(1):61-5
pubmed: 21674766
BMC Public Health. 2012 Jan 25;12:80
pubmed: 22276600
J Public Health (Oxf). 2012 Dec;34(4):570-6
pubmed: 22653886
J Public Health (Oxf). 2013 Dec;35(4):510-7
pubmed: 24169414
J Am Med Inform Assoc. 2014 Jul-Aug;21(4):627-32
pubmed: 24821742
Am J Emerg Med. 2015 Oct;33(10):1396-401
pubmed: 26283616
Prog Cardiovasc Dis. 2016 Jan-Feb;58(4):379-85
pubmed: 26432556
Am J Hematol. 2016 Jan;91(1):5-14
pubmed: 26547630
J Holist Nurs. 2016 Dec;34(4):351-360
pubmed: 26620813
Br J Haematol. 2016 Jul;174(1):136-47
pubmed: 26991317
Am J Med. 2017 May;130(5):601.e9-601.e15
pubmed: 28065771
Hematology. 2018 Oct;23(9):683-691
pubmed: 29595096
Health Educ Q. 1984 Spring;11(1):1-47
pubmed: 6392204

Auteurs

Robert M Cronin (RM)

a Department of Biomedical Informatics , Vanderbilt University Medical Center , Nashville , TN , USA.
b Department of Internal Medicine , Vanderbilt University Medical Center , Nashville , TN , USA.
c Department of Pediatrics , Vanderbilt University Medical Center , Nashville , TN , USA.

Jane S Hankins (JS)

d Department of Hematology , St Jude Children's Research Hospital , Memphis , TN , USA.

Jeannie Byrd (J)

e Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease , Vanderbilt University Medical Center , Nashville , TN , USA.

Brandi M Pernell (BM)

e Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease , Vanderbilt University Medical Center , Nashville , TN , USA.
f Department of Pediatrics, Division of Hematology , University of Alabama at Birmingham , Birmingham , AL , USA.

Adetola Kassim (A)

g Department of Hematology/Oncology , Vanderbilt University Medical Center , Nashville , TN , USA.

Patricia Adams-Graves (P)

h Department of General Internal Medicine and Hematology , University of Tennessee Health Science Center , Memphis , TN , USA.

Alexis Thompson (A)

i Department of Pediatrics, Department of Medicine , Northwestern University , Chicago , IL , USA.

Karen Kalinyak (K)

j Division of Hematology in Cancer and Blood Diseases Institute , University of Cincinnati , Cincinnati , OH , USA.

Michael DeBaun (M)

e Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt-Meharry Center for Excellence in Sickle Cell Disease , Vanderbilt University Medical Center , Nashville , TN , USA.

Marsha Treadwell (M)

k Department of Hematology/Oncology , UCSF Benioff Children's Hospital Oakland , Oakland , CA , USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH